Robert Michael Ussery - 05 Mar 2024 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role: President & COO
Signature: /s/ R. Michael Ussery
Issuer symbol: NHC
Transactions as of: 05 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 07 Mar 2024, 17:02:20 UTC
Previous filing: 26 Feb 2024
Next filing: 14 Mar 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NHC	Shares of Common Stock owned by myself & spouse	Award	$0	+2,563	+1.7%	$0.000000	153,109	05 Mar 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NHC	Option to Purchase Common Stock	Award	$0	+13,500		$0.000000	13,500	05 Mar 2024	Common Stock	13,500	$94.10	Direct	F2, F3
holding	NHC	Option to Purchase Common Stock						4,234	05 Mar 2024	Common Stock	4,234	$63.96	Direct
holding	NHC	Option to Purchase Common Stock						13,500	05 Mar 2024	Common Stock	13,500	$53.94	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2025, the next 33 1/3% vesting on 1/1/2026, and the final 33 1/3% vesting on 1/1/2027.
F2	These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 5, 2024. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F3	These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 5, 2025; one-third (1/3) will vest on March 5, 2026; and the final one-third (1/3) will vest on March 5, 2027.